AZD6750 for squamous cell carcinoma of head and neck

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 29 Jul 2025: Trial started, NCT07115043
  2. 11 Aug 2025: Trial registered, NCT07115043

The trials

NCT07115043: A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

State
Under way
Phase
Phase 1 and Phase 2
People
120 planned
Started
29 Jul 2025
Primary completion
2 Oct 2029
Arms
Module 1
Results
None posted
  1. 29 Jul 2025: Trial started
  2. 11 Aug 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.